Article info
Interstitial lung disease
Original Article
Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development
- Correspondence to Susanne Krauss-Etschmann, Research Center Borstel, Leibniz-Center for Medicine and Biosciences Parkallee 1-40, D-23845 Borstel 23845, Germany; skrauss-etschmann{at}fz-borstel.de
Citation
Pulmonary CCR2+CD4+ T cells are immune regulatory and attenuate lung fibrosis development
Publication history
- Received January 30, 2016
- Revised May 9, 2017
- Accepted May 15, 2017
- First published August 5, 2017.
Online issue publication
September 01, 2022
Article Versions
- Previous version (2 March 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.